Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6AJV

Crystal structure of BRD4 in complex with isoliquiritigenin and DMSO (Cocktail No. 3)

Summary for 6AJV
Entry DOI10.2210/pdb6ajv/pdb
DescriptorBromodomain-containing protein 4, SODIUM ION, 2',4,4'-TRIHYDROXYCHALCONE, ... (5 entities in total)
Functional Keywordsbromodomain, brd4, inhibitor, isoliquiritigenin, transcription
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight16563.92
Authors
Yokoyama, T.,Matsumoto, K.,Nabeshima, Y.,Mizuguchi, M. (deposition date: 2018-08-28, release date: 2019-06-12, Last modification date: 2024-03-27)
Primary citationYokoyama, T.,Matsumoto, K.,Ostermann, A.,Schrader, T.E.,Nabeshima, Y.,Mizuguchi, M.
Structural and thermodynamic characterization of the binding of isoliquiritigenin to the first bromodomain of BRD4.
Febs J., 286:1656-1667, 2019
Cited by
PubMed Abstract: Bromodomain-containing protein 4 (BRD4) recognizes the acetylated lysine of histone H4 via its bromodomains, leading to the recruitment of positive transcription elongation factor b. Small molecules that inhibit BRD4 have potential as anticancer agents by leading to the downregulation of specific oncogenes. Using X-ray crystallographic screening, we identified the BRD4 inhibitory activity of isoliquiritigenin (ISL), a natural chalcone found in licorice. Structural analysis revealed that ISL bound to BRD4 with a novel binding mode and squeezed out one of the six conserved water molecules that form a strong hydrogen bond network. The thermodynamic analysis revealed that the binding of ISL is enthalpy driven, suggesting that strong hydrogen bonds would compensate for the desolvation penalty. Neutron protein crystallography further suggested that the favorable binding enthalpy originates from the stabilization and optimization of the hydrogen bond network of the conserved water molecules. Here, we describe the novelty and potential of ISL as a template for new BRD4 inhibitors.
PubMed: 30565859
DOI: 10.1111/febs.14736
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.45 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon